Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Sep 30, 2022

Accession no.
0001209191-22-051671
Filed
Sep 30, 2022
Trade date
Aug 16-Sep 27, 2022
Filing delay
45 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 30 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.52K. It was filed 45 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 16, 2022Common StockPPurchaseAcquired+20$2.35+$4717,702Direct
Aug 17, 2022Common StockPPurchaseAcquired+20$2.31+$46.217,722Direct
Aug 18, 2022Common StockPPurchaseAcquired+20$2.23+$44.617,742Direct
Aug 19, 2022Common StockPPurchaseAcquired+20$2.35+$4717,762Direct
Aug 22, 2022Common StockPPurchaseAcquired+20$2.51+$50.217,782Direct
Aug 23, 2022Common StockPPurchaseAcquired+20$2.59+$51.817,802Direct
Aug 24, 2022Common StockPPurchaseAcquired+20$2.59+$51.817,822Direct
Aug 25, 2022Common StockPPurchaseAcquired+20$2.62+$52.417,842Direct
Aug 26, 2022Common StockPPurchaseAcquired+20$2.55+$5117,862Direct
Aug 29, 2022Common StockPPurchaseAcquired+22$2.44+$53.6817,884Direct
Aug 30, 2022Common StockPPurchaseAcquired+22$2.38+$52.3617,906Direct
Aug 31, 2022Common StockPPurchaseAcquired+22$2.36+$51.9217,928Direct
Sep 1, 2022Common StockPPurchaseAcquired+22$2.39+$52.5817,950Direct
Sep 2, 2022Common StockPPurchaseAcquired+22$2.42+$53.2417,972Direct
Sep 6, 2022Common StockPPurchaseAcquired+22$2.15+$47.317,994Direct
Sep 7, 2022Common StockPPurchaseAcquired+22$2.24+$49.2818,016Direct
Sep 8, 2022Common StockPPurchaseAcquired+22$2.22+$48.8418,038Direct
Sep 9, 2022Common StockPPurchaseAcquired+20$2.21+$44.218,058Direct
Sep 12, 2022Common StockPPurchaseAcquired+22$2.46+$54.1218,080Direct
Sep 13, 2022Common StockPPurchaseAcquired+22$2.45+$53.918,102Direct
Sep 14, 2022Common StockPPurchaseAcquired+22$2.51+$55.2218,124Direct
Sep 15, 2022Common StockPPurchaseAcquired+22$2.47+$54.3418,146Direct
Sep 16, 2022Common StockPPurchaseAcquired+22$2.49+$54.7818,168Direct
Sep 19, 2022Common StockPPurchaseAcquired+20$2.56+$51.218,188Direct
Sep 20, 2022Common StockPPurchaseAcquired+20$2.54+$50.818,208Direct
Sep 21, 2022Common StockPPurchaseAcquired+20$2.59+$51.818,228Direct
Sep 22, 2022Common StockPPurchaseAcquired+20$2.51+$50.218,248Direct
Sep 23, 2022Common StockPPurchaseAcquired+20$2.55+$5118,268Direct
Sep 26, 2022Common StockPPurchaseAcquired+20$2.49+$49.818,288Direct
Sep 27, 2022Common StockPPurchaseAcquired+20$2.57+$51.418,308Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)